𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia

✍ Scribed by U. Walter; D. Dressler; A. Wolters; M. Wittstock; B. Greim; R. Benecke


Publisher
Springer
Year
2005
Tongue
English
Weight
269 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of dementia with Lewy bodies a
✍ Werner Poewe πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 67 KB

Cognitive decline and dementia affect approximately 30% to 40% of patients with idiopathic Parkinson's disease during the course of their illness. PD-dementia (PDD) and dementia with Lewy bodies (DLB) are second to Alzheimer's disease in causing degenerative dementia in the elderly. The nosological

Current treatment of dementia with Lewy
✍ David J. Burn; Ian G. McKeith πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 81 KB

Dementia in Parkinson's disease (PDD) is a frequent and distressing complication with major consequences. Clinical and pathological features closely link PDD and dementia with Lewy bodies (DLB), suggesting they represent part of the same disease spectrum. Although dopaminergic deficiency primarily d

Comparison of dementia with Lewy bodies
✍ Enrique Noe; Karen Marder; Karen L. Bell; Diane M. Jacobs; Jennifer J. Manly; Ya πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PD‐d). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PD‐d (n = 15) and AD (n = 16

Cholinergic and other neurotransmitter m
✍ Paul T. Francis; Elaine K. Perry πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b